𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Both interleukin 1 and tumor necrosis factor enhance thymocyte proliferation

✍ Scribed by Mikko Hurme

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
413 KB
Volume
18
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor necrosis factor (TNF) receptor typ
Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1
✍ Matthias Grell; Florian M. Becke; Harald Wajant; Daniela N. MΓ€nnel; Peter Scheur πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

Tumor necrosis factor (TNF) mediates its biological effects by binding to two distinct but homologous receptor molecules. The type 1 receptor (TNF-R1) has been shown to be essential and sufficient for most cellular responses to soluble TNF. In contrast, only limited data exist concerning the role of

Circulating interleukin-1 and tumor necr
Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease
✍ Herbert Tilg; Wolfgang Vogel; Christian J. Wiedermann; Leland Shapiro; Manfred H πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 673 KB

The proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha are thought to play important roles in the pathophysiology of liver disease. Specific antagonists of these cytokines have been found in recent years. Interleukin-1 receptor antagonist is a specific interleukin-1 antagonist.